Healthy subjects
Conditions
Interventions
Exercise trials The sprint exercise trial in this study involves a warm-up (5 minutes, 1.5 kg m, 50 W), exercise load (30 seconds, 3.0 kg m), and cool-down (5 minutes, 1.5 kg m, 50 W). After the co
Sponsors
Pharma Foods International,Co.Ltd.
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: 1. Age at the time of obtaining written consent is 20 years or older but less than 65 years for males. 2. Individuals who, after receiving sufficient explanation of the purpose and content of the study, possess the capacity to consent, understand well, and voluntarily express their willingness to participate in the trial by providing written consent.
Exclusion criteria
Exclusion criteria: 1.Individuals currently undergoing medication or outpatient treatment for any serious illness. 2.Individuals currently undergoing exercise or dietary therapy under medical supervision. 3. Individuals with current or past history of substance dependence or alcohol dependence. 4.Individuals currently undergoing outpatient treatment for mental disorders (such as depression) or sleep disorders, or with a history of past mental health disorders. 5.Individuals with irregular lifestyle rhythms due to night shifts or shift work. 6.Individuals with extremely irregular habits in diet, sleep, and other lifestyle factors. 7.Individuals practicing extreme dietary restrictions. 8.Individuals with a history of or current serious diseases, such as brain disorders, malignant tumors, immune disorders, diabetes, liver diseases (hepatitis), kidney diseases, heart diseases, thyroid disorders, adrenal disorders, and other serious metabolic disorders. 9. Individuals regularly consuming supplements containing GABA. 10.Individuals who have participated in another clinical trial (study) within the past 3 months from the date of consent or have plans to participate in another clinical trial (study) during the trial period. 11. Individuals who have donated blood or blood components exceeding 200 mL within the past 1 month or 400 mL within the past 3 months from the date of consent. 12. Individuals who find it difficult to comply with the recording requirements of various survey forms. 13. Any other individuals deemed unsuitable as participants by the trial coordinator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| (Metabolic responses to exercise) 1.Amino acids 2.Lactate 3.Amino acid derivatives * Examine time-course metabolomic changes in blood before and after exercise trials (0,60,120,180 min) * For the endurance exercise trial, blood collection will take place before exercise, 30 minutes during the exercise, and at 0, 60, 120, and 180 min after exercise. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.Physical measurement 2.Vital signs(Blood pressure/heart rate) *During endurance exercise trial, real time heart rate is monitored for maintaining 60% heart reserve rate. | — |
Countries
Japan
Contacts
Public ContactArif Ridwan
Pharma Foods International,Co.Ltd. Research and Development
Outcome results
None listed